Enterprise version of OpenClaw unveiled: NemoClaw runs 24/7 with AI support
NemoClaw extends OpenClaw with enterprise features and enables 24/7 operation with Agentic AI. NVIDIA integration aims to boost performance.
Enterprise solution for continuous operation
Software developer Boobalan M has unveiled a new enterprise version of OpenClaw on Twitter: NemoClaw. The solution was specifically developed for 24/7 operation in businesses and extends the functionality of the open-source project OpenClaw.
Agentic AI integration
A key feature of NemoClaw is the integration of Agentic AI. This technology enables the creation of complex, autonomous agents that can perform tasks without human intervention. The solution aims to help businesses automate processes and increase efficiency.
NVIDIA technology for improved performance
The announcement explicitly mentions the integration of NVIDIA technology. This is intended to enhance NemoClaw's performance and enable faster processing of AI tasks. By utilizing NVIDIA GPUs, compute-intensive AI models can be executed more efficiently.
Open architecture and community
Like the original OpenClaw, NemoClaw is also based on an open architecture. The solution aims to provide businesses with the flexibility to adapt the platform to their specific requirements. The developer community around OpenClaw could thus be expanded.
Availability and target audience
Currently, no information is available about the exact availability and licensing of NemoClaw. The solution is aimed at businesses that require a robust, AI-powered platform for continuous operation. The integration of Agentic AI and NVIDIA technology positions NemoClaw as an enterprise solution for demanding AI applications.
Outlook
With NemoClaw, the OpenClaw ecosystem is expanding to include an enterprise variant. The combination of 24/7 operation, Agentic AI, and NVIDIA integration could open up new possibilities for businesses in automation and AI-powered processes. Further details about technical specifications and pricing models are expected in the coming weeks.